Menu Back toAdvanced Analytics, Cross-Industry Collaboration, and Data Sharing to Change the Paradigm in Clinical Quality
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
DIA 2021 Global Annual Meeting
Advanced Analytics, Cross-Industry Collaboration, and Data Sharing to Change the Paradigm in Clinical Quality
Timothe Claude Menard, PharmD, MSc
- Head of Quality Data Science
- F. Hoffmann- La Roche Ltd, Switzerland
In this session, we will share selected use cases on our collaboration framework. We will also engage with the audience on how we (industry, regulators, patients) can all contribute to a change in paradigm for QA, i.e. where advanced analytics can help detecting and mitigating issues faster, and ultimately accelerate approval and patient access of innovative drugs.
Learning Objective : Examine how advanced analytics are utilized throughout the development lifecycle and how this could lead to a paradigm shift in clinical quality; Describe how the inter company quality analytics (IMPALA) group members collaborate to accelerate the development of advanced analytics for clinical quality; Identify how cross-company data sharing can foster development and validation of advanced analytics.
Jennifer Emerson, PhD, MPH, RN, PMP
- Head of Audit Excellence
- Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
David Donohue, MBA
- Head, Quality Systems and Data Analytics
- GlaxoSmithKline, United States
- Head of Quality Analytics, BioResearch Quality and Compliance
- Johnson & Johnson, United States